Targeting chromatin-mediated epigenetic regulation has emerged as a potential avenue for establishing novel therapeutics for a variety of central anxious process Ailments, which include cognitive Ailments and despair. Histone deacetylase (HDAC) inhibitors have already been pursued as cognitive enhancers that effects the regulation of gene expressio